BeiGene Ltd ADR (NASDAQ:BGNE)

North American company

Market Info

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info

  • Market Cap$8.980bn
  • SymbolNASDAQ:BGNE
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS07725L1026

Company Profile

BeiGene Ltd is a biopharmaceutical company engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. Its product includes BGB-3111, BGB-A317 and BGB-290 and one immuno-oncology agent.